Applied DNA Sciences Inc (APDN)
3.75
-0.34
(-8.31%)
USD |
NASDAQ |
May 03, 16:00
3.785
+0.04
(+0.93%)
After-Hours: 20:00
Applied DNA Sciences Research and Development Expense (Quarterly): 0.9358M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.9358M |
| September 30, 2023 | 0.9389M |
| June 30, 2023 | 0.8361M |
| March 31, 2023 | 0.9887M |
| December 31, 2022 | 0.9713M |
| September 30, 2022 | 0.9129M |
| June 30, 2022 | 0.863M |
| March 31, 2022 | 1.07M |
| December 31, 2021 | 1.080M |
| September 30, 2021 | 1.303M |
| June 30, 2021 | 1.142M |
| March 31, 2021 | 0.9557M |
| December 31, 2020 | 0.7638M |
| September 30, 2020 | 1.240M |
| June 30, 2020 | 0.8146M |
| March 31, 2020 | 0.703M |
| December 31, 2019 | 0.5644M |
| September 30, 2019 | 0.8867M |
| June 30, 2019 | 0.7197M |
| March 31, 2019 | 0.6514M |
| December 31, 2018 | 0.7096M |
| September 30, 2018 | 0.7167M |
| June 30, 2018 | 0.625M |
| March 31, 2018 | 0.6698M |
| December 31, 2017 | 0.7401M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.5247M |
| June 30, 2017 | 0.6031M |
| March 31, 2017 | 0.6359M |
| December 31, 2016 | 0.5186M |
| September 30, 2016 | 0.8392M |
| June 30, 2016 | 1.149M |
| March 31, 2016 | 1.073M |
| December 31, 2015 | 0.673M |
| September 30, 2015 | 0.99M |
| June 30, 2015 | 0.4668M |
| March 31, 2015 | 0.3734M |
| December 31, 2014 | 0.2783M |
| September 30, 2014 | 0.2153M |
| June 30, 2014 | 0.2663M |
| March 31, 2014 | 0.3598M |
| December 31, 2013 | 0.4593M |
| September 30, 2013 | 0.1833M |
| June 30, 2013 | 0.185M |
| March 31, 2013 | 0.1765M |
| December 31, 2012 | 0.1477M |
| September 30, 2012 | 0.1581M |
| June 30, 2012 | 0.10M |
| March 31, 2012 | 0.0961M |
| December 31, 2011 | 0.0785M |
| September 30, 2011 | 0.1072M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.5644M
Minimum
Dec 2019
1.303M
Maximum
Sep 2021
0.931M
Average
0.9358M
Median
Dec 2023
Research and Development Expense (Quarterly) Benchmarks
| Fonar Corp | 0.416M |
| XWELL Inc | -- |
| ProPhase Labs Inc | 0.274M |
| Veracyte Inc | 18.67M |
| OncoCyte Corp | 2.547M |